Allergy, asthma, and proteomics: opportunities with immediate impact
Allergol. immunopatol
; 51(1): 16-21, ene. 2023.
Artigo
em Inglês
| IBECS
| ID: ibc-214035
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Allergy is widely discussed by researchers due to its complex mechanism that leads to disorders and injuries, but the reason behind the allergic status remains unclear. Current treatments are insufficient to improve the patients quality of life significantly. New technologies in scientific and technological development are emerging. For instance, the union between allergy and peptidomics and bioinformatics tools may help fill the gaps in this field, diagnosis, and treatment. In this review, we look at peptidomics and address some findings, such as target proteins or biomarkers that help better understand mechanisms that lead to inflammation, organ damage, and, consequently, poor quality of life or even death (AU)
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Asma
/
Biologia Computacional
/
Proteômica
/
Hipersensibilidade
Limite:
Humanos
Idioma:
Inglês
Revista:
Allergol. immunopatol
Ano de publicação:
2023
Tipo de documento:
Artigo
Instituição/País de afiliação:
Federal University of São Paulo/Brazil